Familial risk of urological cancers: data for clinical counseling

被引:0
|
作者
Kari Hemminki
Xinjun Li
Kamila Czene
机构
[1] German Cancer Research Center (DKFZ),Division of Molecular Genetic Epidemiology
[2] Karolinska Institute,Department of Biosciences at Novum
[3] Karolinska Institute,Department of Medical Epidemiology and Biostatistics
来源
World Journal of Urology | 2004年 / 21卷
关键词
Familial cancers; Heritable cancer; Clinical counseling; Urology;
D O I
暂无
中图分类号
学科分类号
摘要
Familial risks for cancer are important for clinical counseling and understanding cancer etiology. The nationwide Swedish Family-Cancer Database includes all Swedes born in 1932 and later (0 to 68-year-old offspring) with their parents, totaling over 10.2 million individuals. Urological cancer cases were retrieved from the Swedish Cancer Registry up to year 2000. Standardized incidence ratios (SIR) and 95% confidence limits (CI) were calculated for age-specific familial risk in offspring by an exact proband status. The familial risks for offspring cancer were increased at all urological sites from concordant cancer in the parent and in a sibling proband. The highest SIRs by parent were for testicular and prostate cancer (4.26 and 2.45). When a sibling was affected, even kidney cancer (4.74) showed a high SIR. For kidney cancers, and also for prostate and testicular cancers, the SIRs were higher among siblings than among offspring and parents, which may indicate the involvement of recessive effects. Family members of patients with prostate cancer or von Hippel Lindau disease can expect organized clinical counseling, but family members of patients with other urological cancers are probably not counseled. Guidelines for clinical counseling or action level should be developed for all urological cancers because of the established familial risks. Urological cancers also offer a challenge to molecular geneticists attempting to identify the susceptibility genes underlying the familial clustering.
引用
收藏
页码:377 / 381
页数:4
相关论文
共 50 条
  • [1] Familial risk of urological cancers: data for clinical counseling
    Hemminki, K
    Li, XJ
    Czene, K
    WORLD JOURNAL OF UROLOGY, 2004, 21 (06) : 377 - 381
  • [2] Familial risk of cancer: Data for clinical counseling and cancer genetics
    Hemminki, K
    Li, XJ
    Czene, K
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (01) : 109 - 114
  • [3] Clinical utility of histopathology data: urological cancers
    Varma, Murali
    Williamson, Sean
    JOURNAL OF CLINICAL PATHOLOGY, 2022, 75 (08) : 506 - 513
  • [4] Hereditary and Familial Traits in Urological Cancers and Their Underlying Genes
    Hemminki, Kari
    Kiemeney, Lambertus A.
    Morgans, Alicia K.
    Ranniko, Antti
    Pichler, Renate
    Hemminki, Otto
    Culig, Zoran
    Mulders, Peter
    Bangma, Chris H.
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 69
  • [5] Genetic counseling for familial cancer risk
    Weitzel, JN
    HOSPITAL PRACTICE, 1996, 31 (02): : 57 - &
  • [6] Familial risk for colon and rectal cancers
    Hemminki, K
    Chen, BW
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (05) : 809 - 810
  • [7] Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans
    Hemminki, K
    Eng, C
    JOURNAL OF MEDICAL GENETICS, 2004, 41 (11) : 801 - 807
  • [8] Gout patients have an increased risk of developing most cancers, especially urological cancers
    Chen, C-J
    Yen, J-H
    Chang, S-J
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (05) : 385 - 390
  • [9] The role of RNA modification in urological cancers: mechanisms and clinical potential
    Zhou, Xuming
    Zhu, Hezhen
    Luo, Cong
    Yan, Zhaojie
    Zheng, Guansong
    Zou, Xiaofeng
    Zou, Junrong
    Zhang, Guoxi
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [10] The role of RNA modification in urological cancers: mechanisms and clinical potential
    Xuming Zhou
    Hezhen Zhu
    Cong Luo
    Zhaojie Yan
    Guansong Zheng
    Xiaofeng Zou
    Junrong zou
    Guoxi Zhang
    Discover Oncology, 14